HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (30) Citing Articles via Google Scholar Google Scholar Articles by Bowers, L. D. Search for Related Content PubMed PubMed Citation Articles by Bowers, L. D. Related Collections Drug Monitoring and Toxicology Endocrinology and Metabolism Automation and Analytical Techniques Doping in Sports Symposium

Analytical advances in detection of performance-enhancing compounds

Athletic Drug Testing and Toxicology Laboratory, Department of Pathology and Laboratory Medicine, Indiana University Medical Center, 635 Barnhill Dr., Indianapolis, IN 46202-5120. Fax 317-274-7641; e-mail lbowers{at}iupui.edu

Abstract

The use and abuse of performance-enhancing substances has been an issue in sports since the ancient Greeks. The availability of numerous synthetic steroids and recombinant peptide hormones has made testing an analytical challenge. Recent advances in mass spectrometry have provided an opportunity to decrease detection limits. The Atlanta Olympic Games in 1996 marked the first time every specimen was screened by gas chromatography (GC) coupled to high-resolution mass spectrometry (MS). A further improvement may be seen with GC/MS/MS and quadrupole ion traps. Electrospray HPLC/MS has also been applied to the detection and confirmation of peptide hormones in urine. The ability to detect subtle differences in oligosaccharide structure may provide a way to detect abuse of recombinant glycoproteins. Simply decreasing detection limits is not enough; new technology also allows development of a foundation on which to base interpretation. Application of HPLC/MS/MS has allowed direct measurement of steroid conjugates in urine. The relative importance of sulfate, glucuronide, and other conjugates and metabolites of testosterone and epitestosterone can now be assessed. In the international sports arena, the impact of genetic metabolic disposition must also be considered if we are to provide an equitable system. Further research will establish more-refined criteria for the detection threshold of abused substances.

Key Words: indexing terms: sports medicine • abused drugs • drug assays • GC-MS • tandem MS • steroids • peptide hormones • urine • genetic variants

The following articles in journals at HighWire Press have cited this article:

				C. M. McHugh, R. T. Park, P. H. Sonksen, and R. I.G. Holt Challenges in Detecting the Abuse of Growth Hormone in Sport Clin. Chem., September 1, 2005; 51(9): 1587 - 1593. [Abstract] [Full Text] [PDF]

				J. M. Tokish, M. S. Kocher, and R. J. Hawkins Ergogenic Aids: A Review of Basic Science, Performance, Side Effects, and Status in Sports Am. J. Sports Med., September 1, 2004; 32(6): 1543 - 1553. [Abstract] [Full Text] [PDF]

				D. A. Cowan and A. T. Kicman Doping in Sport: Misuse, Analytical Tests, and Legal Aspects Clin. Chem., July 1, 1997; 43(7): 1110 - 1113. [Full Text] [PDF]